• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2019年全球、区域和国家乳腺癌负担及趋势:全球疾病负担研究2019结果

The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019.

作者信息

Xu Shangbo, Liu Yiyuan, Zhang Taofeng, Zheng Jiehua, Lin Weixun, Cai Jiehui, Zou Juan, Chen Yaokun, Xie Yanna, Chen Yexi, Li Zhiyang

机构信息

Department of Internal Medicine, People's Hospital of Jieyang, Jieyang Hospital Affiliated to SunYat-sen University, Jieyang, China.

Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.

出版信息

Front Oncol. 2021 May 21;11:689562. doi: 10.3389/fonc.2021.689562. eCollection 2021.

DOI:10.3389/fonc.2021.689562
PMID:34094989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8176863/
Abstract

BACKGROUND

The burden of breast cancer has been increasing globally. The epidemiology burden and trends need to be updated. This study aimed to update the burden and trends of breast cancer incidences, deaths, and disability-adjusted life-years (DALYs) from 1990 to 2019, using the Global Burden of Disease 2019 study.

METHODS

The data of incidences, deaths, DALYs, and age-standardized rates were extracted. Estimated annual percentage changes were used to quantify the trends of age-standardized rates. Besides, the population attributable fractions of the risk factors of breast cancer were also estimated.

RESULTS

Globally, the incidences of breast cancer increased to 2,002,354 in 2019. High social-development index (SDI) quintiles had the highest incidence cases with a declining trend in age-standardized incidence rate. In 2019, the global deaths and DALYs of breast cancer increased to 700,660 and 20,625,313, respectively. From 1990 to 2019, the age-standardized mortality rates and age-standardized DALY rates declined globally, especially in high and high-middle SDI quintiles. Besides, the trends varied from different regions and countries. The proportion of the patients in the 70+ years age group increased globally. Deaths of breast cancer attributable to high fasting plasma glucose and high body mass index increased globally, and high fasting plasma glucose was the greatest contributor to the global breast cancer deaths.

CONCLUSION

The burden of breast cancer in higher SDI quintiles had gone down while the burden was still on the rise in lower SDI quintiles. It is necessary to appeal to the public to decrease the exposure of the risk factors.

摘要

背景

全球乳腺癌负担一直在增加。流行病学负担和趋势需要更新。本研究旨在利用《2019年全球疾病负担研究》更新1990年至2019年乳腺癌发病率、死亡率和伤残调整生命年(DALYs)的负担及趋势。

方法

提取发病率、死亡率、伤残调整生命年和年龄标准化率的数据。使用估计的年百分比变化来量化年龄标准化率的趋势。此外,还估计了乳腺癌危险因素的人群归因分数。

结果

全球范围内,2019年乳腺癌发病率增至2002354例。社会发展指数(SDI)高五分位数地区发病率最高,且年龄标准化发病率呈下降趋势。2019年,全球乳腺癌死亡人数和伤残调整生命年分别增至700660例和20625313例。1990年至2019年,全球年龄标准化死亡率和年龄标准化伤残调整生命年率下降,尤其是在高SDI五分位数和高中等SDI五分位数地区。此外,不同地区和国家的趋势有所不同。全球70岁及以上年龄组患者的比例有所增加。因空腹血糖高和体重指数高导致的乳腺癌死亡人数在全球范围内增加,空腹血糖高是全球乳腺癌死亡的最大促成因素。

结论

高SDI五分位数地区的乳腺癌负担有所下降,而低SDI五分位数地区的负担仍在上升。有必要呼吁公众减少危险因素的暴露。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/58b88a374baa/fonc-11-689562-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/36af0675b1bf/fonc-11-689562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/a54cf4d3b82f/fonc-11-689562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/f29f38db832b/fonc-11-689562-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/239c18f9ba8f/fonc-11-689562-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/58b88a374baa/fonc-11-689562-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/36af0675b1bf/fonc-11-689562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/a54cf4d3b82f/fonc-11-689562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/f29f38db832b/fonc-11-689562-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/239c18f9ba8f/fonc-11-689562-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdef/8176863/58b88a374baa/fonc-11-689562-g005.jpg

相似文献

1
The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019.1990年至2019年全球、区域和国家乳腺癌负担及趋势:全球疾病负担研究2019结果
Front Oncol. 2021 May 21;11:689562. doi: 10.3389/fonc.2021.689562. eCollection 2021.
2
Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.全球 195 个国家和地区 1990 年至 2017 年乳腺癌发病及归因危险因素负担:2017 年全球疾病负担研究结果。
J Hematol Oncol. 2019 Dec 21;12(1):140. doi: 10.1186/s13045-019-0828-0.
3
Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年青少年和年轻人肌肉骨骼疾病的全球负担和危险因素。
Autoimmun Rev. 2023 Aug;22(8):103361. doi: 10.1016/j.autrev.2023.103361. Epub 2023 May 23.
4
The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017.1990年至2017年全球、区域和国家层面乳腺癌的负担与趋势:全球疾病负担研究2017的结果
Front Oncol. 2020 May 12;10:650. doi: 10.3389/fonc.2020.00650. eCollection 2020.
5
Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021.1990年至2021年204个国家和地区的乳腺癌全球负担及可归因风险因素:全球疾病负担研究2021的结果
Biomark Res. 2024 Aug 26;12(1):87. doi: 10.1186/s40364-024-00631-8.
6
Global Disease Burden and Attributable Risk Factor Analysis of Asthma in 204 Countries and Territories From 1990 to 2019.1990年至2019年204个国家和地区哮喘的全球疾病负担及归因风险因素分析
Allergy Asthma Immunol Res. 2023 Jul;15(4):473-495. doi: 10.4168/aair.2023.15.4.473. Epub 2023 Apr 21.
7
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.全球、区域和国家层面气管、支气管和肺癌的流行病学趋势:一项基于人群的研究。
J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0.
8
Global, regional, and national burden of ovarian cancer and the attributable risk factors in all 194 countries and territories during 2007-2017: A systematic analysis of the Global Burden of Disease Study 2017.2007 - 2017年期间194个国家和地区卵巢癌的全球、区域和国家负担及可归因风险因素:全球疾病负担研究2017的系统分析
J Obstet Gynaecol Res. 2021 Dec;47(12):4389-4402. doi: 10.1111/jog.15019. Epub 2021 Oct 20.
9
Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019.高空腹血糖导致膀胱癌负担的估计:2019 年全球疾病负担研究的结果。
Cancer Med. 2023 Aug;12(15):16469-16481. doi: 10.1002/cam4.6219. Epub 2023 Jun 23.
10
Global Burden of Thyroid Cancer From 1990 to 2017.全球 1990 年至 2017 年甲状腺癌负担研究
JAMA Netw Open. 2020 Jun 1;3(6):e208759. doi: 10.1001/jamanetworkopen.2020.8759.

引用本文的文献

1
Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns.2012 - 2022年伊拉克女性乳腺癌和卵巢癌的发病趋势及其与生育模式的关系
Sultan Qaboos Univ Med J. 2025 May 2;25(1):499-505. doi: 10.18295/2075-0528.2863. eCollection 2025.
2
Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis.优化管腔型乳腺癌的预后评估工具:遗传学见解与综合分析
ESMO Open. 2025 Apr 29;10(5):105080. doi: 10.1016/j.esmoop.2025.105080.
3
Global and China burden of hormone-related cancers and risk factors, 1990-2021: results from the Global Burden of Disease Study 2021.

本文引用的文献

1
Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.临床乳房检查筛查对 20 年后乳腺癌发病率和死亡率的影响:孟买前瞻性、整群随机对照试验。
BMJ. 2021 Feb 24;372:n256. doi: 10.1136/bmj.n256.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Cancer Statistics, 2021.
1990 - 2021年全球及中国激素相关癌症负担与风险因素:全球疾病负担研究2021结果
BMC Public Health. 2025 Apr 28;25(1):1566. doi: 10.1186/s12889-025-22768-3.
4
Application of Metabolic Biomarkers in Breast Cancer: A Literature Review.代谢生物标志物在乳腺癌中的应用:文献综述
Ann Lab Med. 2025 May 1;45(3):229-246. doi: 10.3343/alm.2024.0482. Epub 2025 Mar 17.
5
A comparison of the burden of cancers between 1990 and 2019 in Iran: A national and subnational study.1990年至2019年伊朗癌症负担比较:一项全国及次国家级研究。
PLoS One. 2025 Feb 25;20(2):e0309699. doi: 10.1371/journal.pone.0309699. eCollection 2025.
6
Fear of Cancer Recurrence Prevalence and Its Associated Factors Among Family Caregivers of Women With Breast Cancer: A Systematic Review and Meta-Analysis.乳腺癌女性家庭照顾者的癌症复发恐惧患病率及其相关因素:一项系统评价和荟萃分析
J Clin Nurs. 2025 Jul;34(7):2510-2524. doi: 10.1111/jocn.17680. Epub 2025 Feb 24.
7
Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer.基因组测序提高了男性乳腺癌的诊断率,并拓展了其遗传图谱。
Genet Med Open. 2024 Nov 6;3:101899. doi: 10.1016/j.gimo.2024.101899. eCollection 2025.
8
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.现实世界中转移性乳腺癌患者一线至二线治疗失败的相关因素。
ESMO Open. 2025 Feb;10(2):104125. doi: 10.1016/j.esmoop.2024.104125. Epub 2025 Jan 21.
9
Long-term trends in the incidence of male breast cancer and nomogram for predicting survival in male breast cancer patients: a population-based epidemiologic study.男性乳腺癌发病率的长期趋势及男性乳腺癌患者生存预测列线图:一项基于人群的流行病学研究
Sci Rep. 2025 Jan 15;15(1):2027. doi: 10.1038/s41598-025-85954-8.
10
Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups.使用PR和PIK3CA生物标志物预测乳腺癌预后:诊断组的比较分析
BMC Cancer. 2025 Jan 13;25(1):68. doi: 10.1186/s12885-025-13449-w.
癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
The Devastating Legacy of Breast Cancer Death in Sub-Saharan Africa-Maternal Orphans and a Cycle of Disadvantage.撒哈拉以南非洲地区乳腺癌死亡的毁灭性遗产——母亲孤儿与劣势循环。
JAMA Oncol. 2021 Feb 1;7(2):197-198. doi: 10.1001/jamaoncol.2020.6491.
5
Maternally Orphaned Children and Intergenerational Concerns Associated With Breast Cancer Deaths Among Women in Sub-Saharan Africa.撒哈拉以南非洲地区因乳腺癌死亡的女性所遗留的孤儿及其代际问题
JAMA Oncol. 2021 Feb 1;7(2):285-289. doi: 10.1001/jamaoncol.2020.6583.
6
Population-Based Cancer Registration in Sub-Saharan Africa: Its Role in Research and Cancer Control.撒哈拉以南非洲地区基于人群的癌症登记:其在研究和癌症控制中的作用。
JCO Glob Oncol. 2020 Nov;6:1721-1728. doi: 10.1200/GO.20.00294.
7
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
8
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
9
Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study.撒哈拉以南非洲地区(ABC-DO)的乳腺癌生存状况和生存差距分析:一项前瞻性队列研究。
Lancet Glob Health. 2020 Sep;8(9):e1203-e1212. doi: 10.1016/S2214-109X(20)30261-8.
10
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.绝经激素治疗与妇女健康倡议随机临床试验长期随访中乳腺癌发病率和死亡率的关系。
JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482.